Literature DB >> 11744387

The related murine kinases, Nek6 and Nek7, display distinct patterns of expression.

Erez Feige1, Benny Motro.   

Abstract

Nek6 and Nek7 are evolutionarily conserved murine kinases structurally related to the Aspergillus mitotic-regulator NIMA (Genomics 68 (2000) 187). Comparative in situ examination of their patterns of expression revealed that during early embryogenesis nek6 is highly expressed in primary giant trophoblast cells, while nek7 is expressed in the site of decidual reaction. Later in embryogenesis, both RNAs are almost exclusively restricted to the nervous system. nek6 is found in ventricular and sub-ventricular regions, while nek7 is highly expressed in the dorsal thalamus. In the adult brain, distinct nuclei express the two genes. The lineage- and tissue-specific patterns of expression suggest that the two NIMA-related kinases have (additional) functions that are not related to the mitotic functions of NIMA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11744387     DOI: 10.1016/s0925-4773(01)00573-1

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  16 in total

1.  The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons.

Authors:  Jufang Chang; Robert H Baloh; Jeffrey Milbrandt
Journal:  J Cell Sci       Date:  2009-06-09       Impact factor: 5.285

2.  The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis.

Authors:  Laura O'Regan; Andrew M Fry
Journal:  Mol Cell Biol       Date:  2009-05-04       Impact factor: 4.272

3.  C. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting.

Authors:  John Yochem; Vladimir Lažetić; Leslie Bell; Lihsia Chen; David Fay
Journal:  Dev Biol       Date:  2014-12-16       Impact factor: 3.582

Review 4.  Mitotic kinase cascades orchestrating timely disjunction and movement of centrosomes maintain chromosomal stability and prevent cancer.

Authors:  Janine H van Ree; Hyun-Ja Nam; Jan M van Deursen
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

5.  Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation.

Authors:  Min-Young Lee; Hyun-Ju Kim; Myoung-Ae Kim; Hye Jin Jee; Ae Jeong Kim; Yoe-Sik Bae; Joo-In Park; Jay H Chung; Jeanho Yun
Journal:  Cell Cycle       Date:  2008-09-03       Impact factor: 4.534

6.  Accelerated evolution of an Lhx2 enhancer shapes mammalian social hierarchies.

Authors:  Yuting Wang; Guangyi Dai; Zhili Gu; Guopeng Liu; Ke Tang; Yi-Hsuan Pan; Yujie Chen; Xin Lin; Nan Wu; Haoshan Chen; Su Feng; Shou Qiu; Hongduo Sun; Qian Li; Chuan Xu; Yanan Mao; Yong Edward Zhang; Philipp Khaitovich; Yan-Ling Wang; Qunxiu Liu; Jing-Dong Jackie Han; Zhen Shao; Gang Wei; Chun Xu; Naihe Jing; Haipeng Li
Journal:  Cell Res       Date:  2020-04-01       Impact factor: 25.617

7.  The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis.

Authors:  Nada H Eisa; Yasmeen Jilani; Kashish Kainth; Priscilla Redd; Su Lu; Oulia Bougrine; Houssein Abdul Sater; Chaitanya A Patwardhan; Austin Shull; Huidong Shi; Kebin Liu; Nehal M Elsherbiny; Laila A Eissa; Mamdouh M El-Shishtawy; Anatolij Horuzsko; Roni Bollag; Nita Maihle; Joan Roig; Hasan Korkaya; John K Cowell; Ahmed Chadli
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

8.  The cell adhesion gene PVRL3 is associated with congenital ocular defects.

Authors:  Salil A Lachke; Anne W Higgins; Maiko Inagaki; Irfan Saadi; Qiongchao Xi; Michelle Long; Bradley J Quade; Michael E Talkowski; James F Gusella; Atsuko Fujimoto; Michael L Robinson; Ying Yang; Quynh T Duong; Irit Shapira; Benny Motro; Jun Miyoshi; Yoshimi Takai; Cynthia C Morton; Richard L Maas
Journal:  Hum Genet       Date:  2011-07-17       Impact factor: 4.132

9.  Nek family of kinases in cell cycle, checkpoint control and cancer.

Authors:  Larissa Moniz; Previn Dutt; Nasir Haider; Vuk Stambolic
Journal:  Cell Div       Date:  2011-10-31       Impact factor: 5.130

Review 10.  Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.

Authors:  Sonia Missiroli; Mariasole Perrone; Caterina Boncompagni; Chiara Borghi; Alberto Campagnaro; Francesco Marchetti; Gabriele Anania; Pantaleo Greco; Francesco Fiorica; Paolo Pinton; Carlotta Giorgi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.